Sign in

CIK 0001438533

  • Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
262383102
Phone
+1 888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,495,607
in 10 filings, $79.5M under 10b5-1 plans

Net −$79,495,607. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-05-12 Clague Laura Chief Financial Officer Sale −1,250 $17.16 $21K 20,000
2020-05-12 Clague Laura Chief Financial Officer Sale −527 $16.98 $9K 19,473
2020-05-12 Rosenberg Noah L. Chief Medical Officer Sale −527 $16.98 $9K 26,728
2020-05-11 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −525 $14.95 $8K 26,483
2020-05-11 ROTE WILLIAM E. Senior Vice President, R&D Sale −813 $14.95 $12K 24,833
2020-05-11 Clague Laura Chief Financial Officer Sale −1,250 $14.95 $19K 21,250
2020-05-05 ASELAGE STEVE Director Sale −2,500 $15.88 $40K 253,857
2020-04-08 Bruhn Suzanne Louise Director Grant or award +5,250 5,250
2020-04-08 Bruhn Suzanne Louise Director Grant or award · Stock Option (Right to Buy) +15,750 15,750
2020-03-10 ROTE WILLIAM E. Senior Vice President, R&D Sale −3,250 $14.87 $48K 25,646
2020-03-10 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −3,500 $15.02 $53K 27,008
2020-03-10 Clague Laura Chief Financial Officer Sale −4,000 $15.02 $60K 22,500
2020-03-05 ROTE WILLIAM E. Senior Vice President, R&D Grant or award +3,250 28,896
2020-03-05 REED ELIZABETH E SVP, GC & Corporate Secretary Grant or award +3,500 30,508
2020-03-05 Clague Laura Chief Financial Officer Grant or award +4,000 26,500
2020-03-05 Rosenberg Noah L. Chief Medical Officer Grant or award +5,000 29,045
2020-03-05 Rosenberg Noah L. Chief Medical Officer Sale −1,790 $15.36 $27K 27,255
2020-03-05 ASELAGE STEVE Director Grant or award +12,250 260,716
2020-03-05 ASELAGE STEVE Director Sale −4,359 $15.36 $67K 256,357
2020-02-18 ROTE WILLIAM E. Senior Vice President, R&D Sale −1,250 $16.55 $21K 25,646

Page 43 of 51 · 1,020 trades